Search Results - "RAYMAN, Patricia"

Refine Results
  1. 1
  2. 2

    Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients by KO, Jennifer S, ZEA, Arnold H, DREICER, Robert, BUKOWSKI, Ronald, FINKE, James H, RINI, Brian I, IRELAND, Joanna L, ELSON, Paul, COHEN, Peter, GOLSHAYAN, Ali, RAYMAN, Patricia A, WOOD, Laura, GARCIA, Jorge

    Published in Clinical cancer research (15-03-2009)
    “…Purpose: Immune dysfunction reported in renal cell carcinoma (RCC) patients may contribute to tumor progression. Myeloid-derived suppressor cells (MDSC)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients by FINKE, James H, RINI, Brian, BUKOWSKI, Ronald, IRELAND, Joanna, RAYMAN, Patricia, RICHMOND, Amy, GOLSHAYAN, Ali, WOOD, Laura, ELSON, Paul, GARCIA, Jorge, DREICER, Robert

    Published in Clinical cancer research (15-10-2008)
    “…Purpose: Immune dysfunction is well documented in renal cell carcinoma (RCC) patients and likely contributes to tumor evasion. This dysfunction includes a…”
    Get full text
    Journal Article
  5. 5

    Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma by Raychaudhuri, Baisakhi, Rayman, Patricia, Ireland, Joanna, Ko, Jennifer, Rini, Brian, Borden, Ernest C., Garcia, Jorge, Vogelbaum, Michael A., Finke, James

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2011)
    “…To assess the accumulation of myeloid-derived suppressor cells (MDSCs) in the peripheral blood of patients with glioma and to define their heterogeneity and…”
    Get full text
    Journal Article
  6. 6

    Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained by KO, Jennifer S, RAYMAN, Patricia, IRELAND, Joanna, SWAIDANI, Shadi, GEQIANG LI, BUNTING, Kevin D, RINI, Brian, FINKE, James H, COHEN, Peter A

    Published in Cancer research (Chicago, Ill.) (01-05-2010)
    “…The antiangiogenic drug sunitinib is a receptor tyrosine kinase inhibitor with significant, yet not curative, therapeutic effects in metastatic renal cell…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection by Das Sarma, Jayasri, Burrows, Amy, Rayman, Patricia, Hwang, Mi-Hyun, Kundu, Soumya, Sharma, Nikhil, Bergmann, Cornelia, Sen, Ganes C

    Published in PLoS pathogens (01-11-2020)
    “…The interferon-induced tetratricopeptide repeat protein (Ifit2) protects mice from lethal neurotropic viruses. Neurotropic coronavirus MHV-RSA59 infection of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series by Sun, Lillian, Funchain, Pauline, Song, Jung Min, Rayman, Patricia, Tannenbaum, Charles, Ko, Jennifer, Mcnamara, Michael, Marcela Diaz-Montero, C, Gastman, Brian

    Published in Journal for immunotherapy of cancer (16-05-2018)
    “…Talimogene Laherparepvec (T-VEC) is an oncolytic virus approved as an intratumoral therapy for treating unresectable stage IIIB-IV metastatic melanoma. The…”
    Get full text
    Journal Article
  11. 11

    Unfolded Protein Response Differentially Regulates TLR4-Induced Cytokine Expression in Distinct Macrophage Populations by Zhang, Lei, Pavicic, Jr, Paul G, Datta, Shyamasree, Song, Qiaoling, Xu, Xiaohan, Wei, Wei, Su, Fan, Rayman, Patricia A, Zhao, Chenyang, Hamilton, Thomas

    Published in Frontiers in immunology (21-06-2019)
    “…Cellular stress responses are often engaged at sites of inflammation and can alter macrophage cytokine production. We now report that macrophages in distinct…”
    Get full text
    Journal Article
  12. 12

    Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer by Zamanian-Daryoush, Maryam, Lindner, Daniel J, DiDonato, Joseph A, Wagner, Matthew, Buffa, Jennifer, Rayman, Patricia, Parks, John S, Westerterp, Marit, Tall, Alan R, Hazen, Stanley L

    Published in Oncotarget (22-09-2017)
    “…Increased circulating levels of apolipoprotein A-I (apoA-I), the major protein of high-density lipoprotein (HDL), by genetic manipulation or infusion, protects…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of Activated but not Resting T Cells by SA, Gaurisankar, DAS, Tanya, MOON, Christina, HILSTON, Cynthia M, RAYMAN, Patricia A, RINI, Brian I, TANNENBAUM, Charles S, FINKE, James H

    Published in Cancer research (Chicago, Ill.) (01-04-2009)
    “…We previously elucidated an important role for gangliosides in renal cell carcinoma-mediated T lymphocyte apoptosis, although the mechanism by which they…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Differential gene expression in G-MDSC and neutrophils from renal cell carcinoma patients by Ko, Jennifer, Rayman, Patricia A, Yang, Yu, Gopalan, Banu, Finke, James

    Published in Journal for immunotherapy of cancer (06-11-2014)
    “…Myeloid-derived suppressor cells (MDSC), including undifferentiated, monocytic, and granulocytic subsets, are known to play a role in tumor progression via…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses by RAYMAN, Patricia, WESA, Amy K, FINKE, James, RICHMOND, Amy L, DAS, Tanya, BISWAS, Kaushik, RAVAL, Gira, STORKUS, Walter J, TANNENBAUM, Charles, NOVICK, Andrew, BUKOWSKI, Ronald

    Published in Clinical cancer research (15-09-2004)
    “…Purpose: We reported that in renal cell carcinoma patients with active disease, T-cell reactions to the tumor-associated antigens MAGE-6 and EphA2 are highly…”
    Get full text
    Journal Article Conference Proceeding